Entering Peak Norovirus Season as Cases Rise Across the US
Nationwide norovirus cases have recently increased, followed by an FDA warning for consumers to avoid oysters contaminated in a recent outbreak.
GSK's Arexvy Vaccine Shows Strong Efficacy Against RSV in Older Adults
The vaccine proved a cumulative efficacy of 62.9% against respiratory syncytial virus (RSV)-related lower respiratory tract disease in older adults over 3 seasons.